Fenben For Humans

Fenben for humans has been the subject of intense interest since a man named Joe Tippens cured himself of stage 4 pancreatic cancer with it. While there are few human clinical studies (listed on the world’s largest medical database – PUBMED) of this medication, it has been shown to be very effective at curing multiple forms of deadly cancer in animals.

The anthelmintic drug fenbendazole, or fenben, is used to treat parasites like hookworms, whipworms, roundworms and certain types of tapeworms in animals (under the brand names of Safe-Guard and Panacur). It debuted in scientific trials as a cancer treatment some years ago, but was never given the green light to be marketed for that purpose.

In animal studies, fenbendazole has been shown to disrupt microtubules in cells. These are structures that help keep cell structures, like DNA and proteins, in place. Cancer cells rely on microtubules to grow and divide, so by disrupting them fenbendazole may be able to cause cancer cell death.

When we studied fenbendazole’s effects on cultured cancer cells, we found that it did inhibit glucose uptake (as measured by the fluorescent glucose analogue 2-NBDG). This resulted in decreased lactate levels in the cells. The results support the hypothesis that fenbendazole’s anthelmintic effects in animals and in cultured cancer cells are related to inhibition of glucose uptake.